Literature DB >> 15601405

Home haemodialysis in remote Australia.

Angelina Villarba1, Kevin Warr.   

Abstract

The Royal Perth Hospital provides access to dialysis treatment to Indigenous Australians living in remote areas of Western Australia who are suffering from end-stage renal disease (ESRD). The Remote Area Dialysis Programme (RADP), established in 1989, relocated traditional hospital services to remote communities and introduced home or community-based therapy. This unique state-wide programme was developed in cooperation with tribal elders in Aboriginal communities, and regional medical, nursing and community health staff. Prior to RADP's establishment, these patients faced the choice of permanent relocation to Perth for dialysis treatment or death from renal failure. Development of the RADP allowed Indigenous patients with ESRD to receive dialysis treatment in their own home/community. Requirements for home haemodialysis include establishing the suitability and capability of patients, the availability of carers and an appropriate home or community environment for dialysis machine installation. This has required novel strategies to address cultural and language impediments to home therapy. The remoteness of some isolated communities has been a technical challenge for the dialysis technicians due to the uncertainty of power supply, climatic extremes and inadequate supply or poor quality of water. A specific training program has been developed to adapt to the needs of Aboriginal patients. Patients undertaking home haemodialysis face many challenges and a number of initiatives will need to be implemented to ensure the ongoing success of the programme.

Entities:  

Mesh:

Year:  2004        PMID: 15601405     DOI: 10.1111/j.1440-1797.2004.00349.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  8 in total

1.  Travel distance and home dialysis rates in the United States.

Authors:  Suma Prakash; Rick Coffin; Jesse Schold; Steven A Lewis; Douglas Gunzler; Susan Stark; Matthew Howard; Darlene Rodgers; Douglas Einstadter; Ashwini R Sehgal
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

2.  A Discrete Choice Study of Patient Preferences for Dialysis Modalities.

Authors:  Rachael C Walker; Rachael L Morton; Suetonia C Palmer; Mark R Marshall; Allison Tong; Kirsten Howard
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-19       Impact factor: 8.237

3.  Service providers' perspectives, attitudes and beliefs on health services delivery for Aboriginal people receiving haemodialysis in rural Australia: a qualitative study.

Authors:  Elizabeth F Rix; Lesley Barclay; Shawn Wilson; Janelle Stirling; Allison Tong
Journal:  BMJ Open       Date:  2013-10-23       Impact factor: 2.692

4.  'Beats the alternative but it messes up your life': aboriginal people's experience of haemodialysis in rural Australia.

Authors:  Elizabeth F Rix; Lesley Barclay; Janelle Stirling; Allison Tong; Shawn Wilson
Journal:  BMJ Open       Date:  2014-09-17       Impact factor: 2.692

5.  Interventions to Improve Clinical Outcomes in Indigenous or Remote Patients With Chronic Kidney Disease: A Scoping Review.

Authors:  N Ovtcharenko; B K A Thomson
Journal:  Can J Kidney Health Dis       Date:  2019-11-14

6.  The perspectives of Aboriginal patients and their health care providers on improving the quality of hemodialysis services: a qualitative study.

Authors:  Elizabeth F Rix; Lesley Barclay; Janelle Stirling; Allison Tong; Shawn Wilson
Journal:  Hemodial Int       Date:  2014-07-23       Impact factor: 1.812

7.  Difficult conversations: Australian Indigenous patients' views on kidney transplantation.

Authors:  Jeannie Devitt; Kate Anderson; Joan Cunningham; Cilla Preece; Paul Snelling; Alan Cass
Journal:  BMC Nephrol       Date:  2017-10-11       Impact factor: 2.388

8.  Patients' Experiences of Community House Hemodialysis: A Qualitative Study.

Authors:  Rachael C Walker; David Tipene-Leach; Aria Graham; Suetonia C Palmer
Journal:  Kidney Med       Date:  2019-09-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.